CALC CalciMedica, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

CalciMedica (CALC) Stock: Buy, Sell, or Hold?

$1.21
-0.01 (-0.82%) β–Ό
5d: -11.03% 30d: +12.04% 90d: +82.64%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (58%)
Quality Score
39/100
Position
SLIGHTLY LOW
30-Day Fair Range
$1.12 – $1.49
Position: SLIGHTLY LOW
Forward P/E & Valuation
-0.2x
Next 12M consensus est.
Wall Street Target
$38.00
+3040.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.16 / $1.75
Trend: Uptrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: CALC is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When CALC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: CALC is currently trading at $1.21, which is considered slightly low relative to its 30-day fair value range of $1.12 to $1.49.

Technical Outlook: Technically, CALC is in a uptrend. Immediate support is located at $1.16, while resistance sits at $1.75.

Market Sentiment: CALC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $38.00 (+3040.5%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $1.12 - $1.49
Company Quality Score 39/100 (SELL)
Volume Confirmation HIGH
Confidence Score 57.9%

Trading Range & Key Levels

30-Day Trading Range $1.12 - $1.49
Current vs Trading Range SLIGHTLY LOW
Support Level $1.16
Resistance Level $1.75
Current Trend Uptrend
Technical data as of Nov 13, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (15/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 3040.5% below Wall St target ($38.00)
  • WARNING: Composite score 39/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -0.19
Wall Street Target $38.00 (+3040.5%)
Share CALC Analysis

Share this live CALC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (CALC)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary: CalciMedica Inc. (CALC) received a Zacks Rank #2 (Buy) due to an upward trend in earnings estimates, which could lead to buying pressure and a potential increase in the stock price.
Key Retail Themes: positive earnings revisions Zacks Rank upgrade
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 6:09 PM ET
Data refreshes hourly during market hours. Next update: 7:09 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CALC.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
KYMR
Kymera Therapeutics Inc
STRONG BUY
24 analysts
$145 49 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
22 analysts
$107 42 HOLD
ARGX
argenx NV ADR
STRONG BUY
23 analysts
$1147 33 SELL
IRD
Opus Genetics, Inc.
STRONG BUY
18 analysts
$13 39 SELL
DNTH
Dianthus Therapeutics In…
STRONG BUY
18 analysts
$139 35 SELL

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive CALC Research Pages
CALC Technical Chart CALC Price Prediction CALC Intrinsic Value DCF CALC Earnings Date CALC Investment Advisor CALC Fair Price Analyzer CALC Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals